Rutabaga Capital Management’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-29,731
Closed -$974K 48
2022
Q2
$974K Sell
29,731
-17,400
-37% -$550K 0.78% 28
2022
Q1
$1.24M Hold
47,131
0.78% 36
2021
Q4
$1.12M Sell
47,131
-53,300
-53% -$1.32M 0.74% 39
2021
Q3
$2.52M Sell
100,431
-15,750
-14% -$401K 1.22% 34
2021
Q2
$3.02M Hold
116,181
1.31% 33
2021
Q1
$2.98M Sell
116,181
-4,450
-4% -$114K 1.37% 32
2020
Q4
$2.42M Sell
120,631
-48,112
-29% -$942K 1.45% 34
2020
Q3
$2.89M Sell
168,743
-23,900
-12% -$452K 1.64% 36
2020
Q2
$4.2M Sell
192,643
-10,116
-5% -$232K 2.3% 19
2020
Q1
$4.69M Buy
202,759
+6,550
+3% +$190K 2.81% 11
2019
Q4
$6.47M Sell
196,209
-46,047
-19% -$1.48M 2.49% 15
2019
Q3
$7.71M Sell
242,256
-152,223
-39% -$4.44M 2.73% 10
2019
Q2
$10.1M Sell
394,479
-83,963
-18% -$2.14M 2.89% 19
2019
Q1
$12.1M Buy
478,442
+115,575
+32% +$3.45M 3.36% 10
2018
Q4
$12.3M Buy
362,867
+102,791
+40% +$3.34M 4.07% 1
2018
Q3
$9.27M Buy
+260,076
New +$9.18M 2.13% 20

Other funds holding NTUS

Rutabaga Capital Management's NTUS Position: Q3 2022 in Review

Rutabaga Capital Management sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 29,731 shares — an estimated $974K sold.

Rutabaga Capital Management first reported a position in NTUS in Q3 2018 and held it in 16 quarters. The position peaked at $12.3M in Q4 2018. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Rutabaga Capital Management reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Rutabaga Capital Management sold 29,731 Natus Medical Inc shares in Q3 2022, an estimated $974K.
  • Rutabaga Capital Management first reported a position in Natus Medical Inc in Q3 2018 and held it in 16 quarters.
  • Rutabaga Capital Management's Natus Medical Inc position peaked at $12.3M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Rutabaga Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.